Staff and volunteers with organizations that work with Winnipeg's homeless community are now on the growing list of those ...

Orsini, a leader in rare disease pharmacy solutions, announced today that it is the contracted specialty pharmacy for Gilead's Hepcludex® (bulevirtide?gmod) 8.5 mg, a subcutaneous injection for the ...

Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 ...

Experts say Rochester's bid to restrict needle exchanges in response to residents who complain will make the city's drug ...

For four years, the city and county health department gave out pipes and other supplies to reduce the health risks of smoking drugs. Officials say the program worked. But it conflicted with state ...

Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis delta virus (HDV) infection. The approval makes ...

Americans’ enthusiasm for injection has never been higher.

By partnering with a UN-backed body, Roche has enabled companies to make the medicine for supply in 129 countries.

Federal prosecutors allege that Christopher Barret Johnson, an ex-employee of a harm reduction organization that has served ...

The Ebola outbreak in central Africa sparked by the rare Bundibugyo strain, for which no vaccines or therapies are licensed, has triggered urgency to get a shot in the pipeline, Carmen writes. Two ...

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy) data in adults with relapsing forms of multiple sclerosis (RMS) ...